Fig. 2From: Impurity profiling method development and validation of metformin hydrochloride and teneligliptin hydrobromide hydrate in their combination tablet dosage form by using RP-HPLC with UV/PDA detectora Representative chromatogram of blank solution. b Representative chromatogram of placebo solution. c Representative chromatogram of system suitability solution. d Representative chromatogram of sample solutionBack to article page